TBNHealth
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
Publication: STAT
Author: Ed Silverman
Source published: 16/10/2026, 13:49:21 UTC
Briefing created: 16/10/2026, 13:58:21 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/10/2026, 13:51:24 UTC.
Briefings
The Trump administration plans to permit compounding pharmacies to produce unapproved peptides, a class of injections popular among U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and wellness influencers. The peptides have not received FDA approval, and most available data comes from animal studies. China is considering adding five biomedical technologies to its export-control list, including two platforms for genetic-level disease treatment, though restrictions do not apply to licensing, partnerships, or contract research services involving these technologies.
Key points
- The Trump administration plans to allow compounding pharmacies to produce certain peptides, a class of largely unregulated injections popular among U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and other wellness influencers.
- China is proposing to add five biomedical technologies to its export-control list, including two types of cutting-edge medical technology platforms to treat diseases at a genetic level.
Context
This briefing covers the Trump administration's plan to allow compounding pharmacies to produce unapproved peptides, which are popular among U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and other wellness influencers. It also notes China's proposal to add five biomedical technologies to its export-control list, including two platforms for genetic-level disease treatment.
Limitations
Evidence is limited to AP and Bloomberg Law reports; specific data sources, dates, or numbers are not provided. Findings remain unverified and may change as new information emerges.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/10/2026, 13:58:21 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeifinp5eekrka4ql3fy24mo4ev6wirr4uhkqkne4hm43feiijagz34